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Background and aims: Fetal exposure to endocrine disruptors such as phthalates and bisphenols may lead to 
developmental metabolic adaptations. We examined associations of maternal phthalate and bisphenol urine 
concentrations during pregnancy with lipids, insulin, and glucose concentrations at school age. 
Methods: In a population-based, prospective cohort study among 757 mother–child pairs, we measured maternal 
phthalate and bisphenol urine concentrations in first, second and third trimester of pregnancy. We measured 
non-fasting lipids, glucose and insulin blood concentrations of their children at a mean age of 9.7 (standard 
deviation 0.2) years. Analyses were performed for boys and girls separately. 
Results: An interquartile range (IQR) higher natural log transformed third trimester maternal urine phthalic acid 
concentration was associated with a 0.20 (95% confidence interval (CI) 0.07–0.34) standard deviation score 
(SDS) higher triglycerides concentration among boys. Maternal bisphenol urine concentrations were not asso-
ciated with non-fasting lipid concentrations during childhood. An IQR higher natural log transformed second 
trimester maternal high molecular weight phthalates (HMWP) and di-2-ethylhexylphthalate (DEHP) urine 
concentration were associated with a 0.19 (95% CI 0.31–0.07) respectively 0.18 (95% CI 0.31–0.06) SDS lower 
glucose concentration among boys. An IQR higher natural log transformed third trimester maternal bisphenol F 
urine concentration was associated with a 0.22 (95% CI 0.35–0.09) SDS lower non-fasting insulin concentration 
among boys. 
Conclusions: Our results suggest potential persisting sex specific effects of fetal exposure to phthalates and bi-
sphenols on childhood lipid concentrations and glucose metabolism. Future studies are needed for replication 
and exploring underlying mechanisms.   
1. Introduction 
Endocrine-disrupting chemicals (EDCs), such as phthalates and bi-
sphenols, are widely used in food packaging, household products and 
medical devices (Ye et al., 2008; Russo et al., 2019; Schettler, 2006). 
Fetal life may be a specific critical period for the possible effects of 
phthalates and bisphenols because they pass the placenta (Nahar et al., 
2015; Mose et al., 2007). The mechanisms by which phthalates and 
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bisphenols may affect fetal development are by stimulating estrogen 
and inhibiting androgen receptors, activating peroxisome proliferator- 
activated receptors (PPARs) or retinoid X receptors (RXRs), and chan-
ging the fetal transcriptome (Mattison et al., 2014). Thus far, cross- 
sectional studies in adult populations showed inconsistent results for 
the associations of phthalates and bisphenols with several metabolic 
diseases in humans, such as obesity, hypertension and diabetes 
(Ranciere et al., 2015; Golestanzadeh et al., 2019; James-Todd et al., 
2012). 
Currently, only limited prospective studies on the associations of 
fetal exposure to phthalates or bisphenols with metabolic diseases are 
available and they showed no clear association of fetal exposure to 
phthalates or bisphenols with childhood lipid and glucose metabolism 
(Vafeiadi et al., 2016, 2018; Perng et al., 2017; Watkins et al., 2016). In 
a Greek cohort study, first trimester bisphenol A (BPA) urine con-
centrations were not associated with non-fasting lipid concentrations at 
4 years, while third trimester phthalates urine concentrations were 
negatively associated with non-fasting high density lipoprotein (HDL)- 
cholesterol concentrations at 4 years, but not with cholesterol con-
centrations or metabolic outcomes at 6 years (Vafeiadi et al., 2016, 
2018). In another study among 227 mother–child pairs from Mexico, no 
consistent associations were found for pregnancy-averaged maternal 
urine BPA or phthalate concentrations with lipid profiles among 8–14- 
year-old children (Perng et al., 2017). Sex- and pubertal status-depen-
dent associations were observed of third trimester phthalate and BPA 
exposures with C-peptide and fasting glucose at 8–14 years (Watkins 
et al., 2016). Although the previous studies explored sex-specific asso-
ciations, the study populations were smaller than 300 subjects and thus 
might have been underpowered. 
We hypothesized that fetal exposure to phthalates and bisphenols 
leads to fetal metabolic adaptations, which persistently affect glucose 
and lipid metabolism. We assessed the sex-specific associations of ma-
ternal phthalate and bisphenol urine concentrations in first, second and 
third trimester of pregnancy with non-fasting lipids, glucose and insulin 
concentrations in their children at the age of 10 years. 
Table 1 
Urinary concentrations of phthalates and bisphenols during pregnancy, stratified in boys and girls.          
First trimester 
Median (25th-75th percentile) 
Second trimester 
Median (25th-75th percentile) 
Third trimester 
Median (25th-75th percentile) 
Boys Girls Boys Girls Boys Girls  
Phthalic Acid (PA) (nmol/L) 343.1 
(179.4–645.5) 
365.1 
(185.0–779.4) 
903.8 
(372.0–1658.6) 
832.3 
(337.8–1687.7) 
368.7 
(188.9–778.0) 
419.5 
(219.9–889.9) 
Low-molecular-weight phthalates (LMWP) (nmol/L) 1094.8 
(477.8–2653.5) 
1102.0 
(400.8–3118.0) 
520.5 
(228.1–1281.0) 
573.8 
(221.4–1659.0) 
921.1 
(372.6–2244.8) 
1008.3 
(410.7–2773.1) 
Monomethylphthalate (mMP) (nmol/L) 28.7 
(15.1–54.5) 
30.2 
(15.3–55.7) 
17.9 
(9.9–33.6) 
19.1 
(9.3–35.4) 
19.4 
(10.2–37.8) 
24.8 
(11.6–52.7) 
Monoethylphthalate (mEP) (nmol/L) 677.8 
(210.3–2329.3) 
710.8 
(208.1–2574.9) 
315.4 
(112.6–970.4) 
376.9 
(124.0–1409.1) 
581.0 
(205.4–1818.1) 
658.1 
(219.9–2378.1) 
Mono-isobutylphthalate (mIBP) (nmol/L) 101.5 
(45.9–217.6) 
98.1 
(43.0–191.3) 
36.5 
(19.3–78.6) 
39.9 
(18.8–78.8) 
69.3 
(39.7–138.3) 
84.2 
(43.8–174.4) 
Mono-n-butylphthalate (mBP) (nmol/L) 78.5 
(32.5–150.0) 
72.6 
(32.7–140.2) 
43.0 
(23.5–82.7) 
41.3 
(22.3–85.6) 
52.9 
(27.2–97.2) 
56.9 
(28.0–117.1) 
High molecular-weight phthalates (HMWP) (nmol/L) 217.3 
(111.0–414.9) 
218.4 
(115.8–385.5) 
131.8 
(73.7–242.3) 
121.9 
(67.8–221.4) 
156.7 
(92.5–268.9) 
178.2 
(97.4–318.1) 
Monobenzylphthalate (mBzBP) (nmol/L) 22.0 
(8.7–47.9) 
22.4 
(9.4–47.8) 
19.6 
(7.7–37.5) 
19.2 
(8.2–42.5) 
10.8 
(3.9–23.7) 
12.8 
(4.1–25.2) 
Mono-hexylphthalate (mHxP) (nmol/L) 1.0 
(0.4–2.2) 
0.9 
(0.3–1.9) 
NA NA NA NA 
Mono-2-heptylphthalate (mHpP) (nmol/L) 2.1 
(0.8–5.3) 
2.1 
(0.8–5.5) 
NA NA NA NA 
Monocyclohexyl-phthalate (mCHP) (nmol/L) 0.1 
(0.1–0.1) 
0.1 
(0.1–0.1) 
NA NA NA NA 
Di-2-ehtylhexylphthalate (DEHP) (nmol/L) 171.9 
(89.8–315.1) 
174.2 
(89.9–300.7) 
96.8 
(49.9–184.2) 
89.4 
(48.2–164.9) 
132.3 
(75.3–225.9) 
146.8 
(80.3–274.1) 
Mono-(2-ethyl-5-carboxy-pentyl)phthalate (mECPP) (nmol/L) 51.6 
(25.9–100.0) 
51.2 
(27.1–99.4) 
33.8 
(17.4–64.9) 
30.6 
(17.8–58.6) 
54.1 
(28.9–103.7) 
59.8 
(30.4–110.3) 
Mono-(2-ethyl-5-hydroxy-hexyl)phthalate (mEHHP) (nmol/L) 41.4 
(20.8–79.9) 
43.5 
(20.5–75.0) 
19.2 
(10.0–37.1) 
17.8 
(9.2–34.2) 
31.0 
(17.1–59.4) 
39.4 
(18.2–75.2) 
Mono-(2-ethyl-5oxohexyl)phthalate (mEOHP) (nmol/L) 27.0 
(12.1–55.6) 
26.5 
(12.5–49.5) 
25.2 
(12.4–57.5) 
22.5 
(10.6–52.5) 
22.0 
(13.3–42.3) 
26.9 
(14.0–50.0) 
Mono-[(2-carboxymethyl)-hexyl] phthalate (mCMHP) (nmol/L) 44.2 
(24.3–67.8) 
46.9 
(24.5–83.2) 
12.51 
(6.8–24.2) 
12.3 
(6.9–22.9) 
9.7 
(6.0–19.7) 
12.4 
(5.7–22.5) 
Di-n-octylphthalate (DNOP) 5.7 
(3.2–11.2) 
6.4 
(2.9–10.7) 
3.5 
(2.0–6.8) 
3.3 
(1.9–6.1) 
6.6 
(3.7–12.1) 
6.9 
(3.8–13.2) 
Mono(3-carboxypropyl)- phthalate (mCPP) (nmol/L) 5.7 
(3.2–11.2) 
6.4 
(2.9–10.7) 
3.5 
(2.0–6.8) 
3.3 
(1.9–6.1) 
6.6 
(3.7–12.1) 
6.9 
(3.8–13.2) 
Bisphenols (nmol/L) 9.7 
(3.6–21.7) 
8.7 
(3.4–21.6) 
6.0 
(2.8–12.5) 
5.8 
(2.9–13.5) 
8.4 
(3.8–17.0) 
10.0 
(4.5–19.3) 
Bisphenol A (BPA) (nmol/L) 5.0 
(1.0–12.4) 
4.6 
(1.0–15.0) 
5.7 
(2.6–11.6) 
5.1 
(2.5–11.8) 
5.9 
(2.5–11.0) 
7.0 
(2.8–13.2) 
Bisphenol S (BPS) (nmol/L) 0.8 
(0.1–3.0) 
0.6 
(0.1–2.3) 
0.1 
(0.1–0.5) 
0.1 
(0.1–0.4) 
NA NA 
Bisphenol F (BPF) (nmol/L) 0.6 
(0.6–1.7) 
0.6 
(0.6–2.4) 
NA NA 0.6 
(0.6–2.6) 
0.6 
(0.6–1.3) 
Values represent medians (25th-75th percentiles). Absolute urinary concentration of the grouped exposures (in nmol/L urine) and individual exposures (in nmol/L 
urine) with concentrations below the limit of detection imputed as limit of detection/square root of 2. Only values that are included in the calculation of the grouped 
exposures are included in this table. 
NA: not applicable due to  >  80% of concentrations below limit of detection.  
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2. Materials and methods 
2.1. Study design 
This study was embedded in the Generation R Study, a population- 
based prospective cohort study from early fetal life onwards in 
Rotterdam, the Netherlands (Jaddoe et al., 2012). Phthalate and bi-
sphenol concentrations were measured among a subgroup of 1,405 
mothers, whose singleton children also participated in postnatal stu-
dies. We excluded mothers without information on phthalate and bi-
sphenol urine concentrations for at least one time point in pregnancy 
and whose children had no measurement of metabolic risk factors at 
10 years. The population for analysis comprises 757 mother–child pairs 
(the specific sample per outcome is shown in Supplemental Fig. 1). The 
study protocol confirms to the ethical guidelines of the 1975 Declara-
tion of Helsinki and has been approved by the Medical Ethical Com-
mittee of the Erasmus MC, University Medical Centre in Rotterdam. 
Written informed consent was obtained from all participants. 
2.2. Maternal phthalate and bisphenol urine concentrations 
Phthalate and bisphenol concentrations were measured in spot 
urine samples obtained from each woman at three time points during 
pregnancy (median 12.9 weeks of gestation (25th-75th percentiles 
12.1–14.6); median 20.4 weeks of gestation (25th-75th percentiles 
19.9–20.9); median 30.2 weeks of gestation (25th-75th percentiles 
29.9–30.8)). These periods were considered as first, second and third 
trimester. Urine samples were collected between February 2004 and 
July 2005. The analyses of phthalate, bisphenol and creatinine con-
centrations were performed at the Wadsworth Center, New York State 
Department of Health, Albany, New York, USA, using previously de-
scribed methods (Philips et al., 2018). Urine biomarkers for exposure to 
phthalate metabolites were grouped according to their molecular 
weight and parent phthalates into low molecular weight phthalates 
(LMWP) and high molecular weight phthalates (HMWP), which in-
cludes subgroups of di-2-ethylhexylphthalate (DEHP) and di-n-oc-
tylphthalate (DNOP) metabolites. Phthalic acid (PA) was analyzed se-
parately as a proxy for total phthalate exposure. Bisphenols A (BPA), S 
(BPS) and F (BPF) were grouped and used as proxy for total bisphenol 
exposure. Weighted molar sums were calculated for the different groups 
of phthalates and bisphenols. Individual phthalates and bisphenols 
were included in the groups if  <  80% of their concentrations at that 
time point was below the limit of detection (LOD). All concentrations 
below the LOD were substituted by LOD divided by the square root of 2 
(LOD/√2) (Hornung, 1990). The descriptive statistics of the individual 
and grouped phthalates and bisphenols investigated are shown for boys 
and girls in Table 1 and for the total group in Supplemental Table S1. 
The intraclass correlation coefficients between the grouped natural log- 
transformed phthalates and bisphenols across pregnancy were assessed 
using a single measurement, absolute agreement and two-way mixed 
effects model and varied between 0.06 and 0.35 (Supplemental Table 
S1). We also assessed the Pearson’s correlation coefficients between all 
natural log-transformed creatinine-corrected phthalates and bisphenols 
which showed that the overall correlations were low-moderate, espe-
cially between different trimesters and different groups (Supplemental 
Table S2). To account for urinary dilution, urine concentrations of 
phthalates and bisphenols were converted to µmol/g creatinine for the 
metabolite groups. To reduce the potential for exposure misclassifica-
tion due to temporal variability, we calculated the overall mean ex-
posure during pregnancy by summing the first, second and third tri-
mester phthalate and bisphenol urine concentrations and dividing that 
by the three time points. 
2.3. Childhood metabolic risk factors 
As described previously, children were invited to visit our research 
center around the age of 10 years (Kooijman et al., 2016). We obtained 
non-fasting venous blood samples and measured total cholesterol, HDL- 
cholesterol, triglycerides, glucose and insulin concentrations. Total 
cholesterol, HDL-cholesterol, triglycerides and glucose concentrations 
were measured on the Cobas 8000 analyzer using the c702 module. 
Insulin was measured with electrochemiluminescence immunoassay 
(ECLIA) on the E411 module (Roche, Almere, the Netherlands) 
(Kruithof et al., 2014). Low-density lipoprotein (LDL)-cholesterol was 
calculated according to the Friedewald formula (Onyenekwu et al., 
2014). For the assessment of the risk of adverse cardio-metabolic risk 
factors, children were divided into groups based on their concentrations 
of triglycerides, HDL-cholesterol, LDL-cholesterol and insulin. The 75th 
percentile was used as the cut-off for triglycerids (≥1.3000 mmol∕l), 
LDL-cholesterol (≥2.6927 mmol∕l) and insulin (≥310.0500 pmol∕l) 
and the 25th percentile was used as the cut-off for HDL-cholesterol 
(≤1.2300 mmol∕l). 
2.4. Covariates 
Information on maternal characteristics, including age, ethnicity, 
pre-pregnancy body mass index, use of folic acid supplementation, 
educational level, parity, and maternal smoking habits and alcohol 
consumption (specifically in first, second and third trimester of preg-
nancy or during pregnancy) and maternal diet were obtained from 
questionnaires during pregnancy. To assess maternal diet, a previously 
developed food-based diet quality score was used, reflecting adherence 
to national dietary guidelines (Nguyen et al., 2017). Child’s sex was 
obtained from midwife and hospital records at birth. Weight and height 
were measured during the visit at our research center to calculate the 
child’s body mass index (BMI), which was then standardized for age and 
sex. A simplified Directed Acyclic Graph (DAG) showing the hypothe-
sized relationship between fetal exposure to phthalates and bisphenols, 
childhood metabolic risk factors and the covariates is presented in 
Supplemental Fig. 2. 
2.5. Statistical analysis 
For all analyses, maternal phthalate and bisphenol urine con-
centrations were natural log-transformed to reduce variability and ac-
count for right skewness of the distribution and further standardized by 
the interquartile range (IQR) to ease the interpretation of effect sizes. 
We also natural log-transformed the non-normally distributed child-
hood metabolic risk factors (triglycerides and insulin) and constructed 
standard-deviation scores (SDS) [(observed value - mean)/SD] of the 
sample distribution of all outcomes to enable comparisons of effect 
sizes. Participants were compared with non-participants on all ex-
posures and covariates by using Chi-square tests, student’s t-tests and 
Mann-Whitney U tests, when applicable. 
We assessed linearity of the associations of maternal phthalate and 
bisphenol urine concentrations (per time point and overall mean during 
pregnancy) with childhood metabolic risk factors by assessing the re-
siduals of the regression in a P-P plot, assessing homoscedascity and 
multicollinearity and used linear regression models if the residuals were 
normally distributed, the residuals were homoscedastic and if the var-
iance inflation factors were below 5.00. To examine the independent 
associations of maternal first, second and third trimester phthalate and 
bisphenol urine concentrations with childhood metabolic risk factors, 
we created a mutually adjusted model by simultaneously including in 
the model the exposures at all three time points during pregnancy, after 
testing whether there were no issues with multicollinearity 
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(correlations  <  0.70) (Supplemental Table S1). We used logistic re-
gression to assess the associations of maternal urine phthalate or bi-
sphenol concentrations with being in the highest risk-category. 
First, models were adjusted for child’s age and sex only (basic 
model). Potential confounders were identified based on the graphical 
criteria for confounding by visualizing a DAG and then we included 
those in the models that changed the effect estimates  >  10% for at 
least one of the outcomes (Santos et al., 2019). The inclusion of 
childhood BMI in the model marginally decreased the effect estimates 
and we only present the fully adjusted models including childhood BMI. 
As a sensitivity analysis, we performed the analyses of insulin with 
glucose included in the model because non-fasting samples were used 
and the time since the last meal was unknown. Based on our hypothesis 
of sex-specific effects and based on the influence of folic acid on the 
metabolism of phthalates and bisphenols, we tested for statistical in-
teraction of child’s sex. We also tested for statistical interaction of folic 
acid supplement use, since folic acid can influence methylation and one 
of the proposed mechanisms by which phthalates and bisphenols exert 
their influence could by through changes in DNA methylation (Gules 
et al., 2019; Dolinoy et al., 2007; Pauwels et al., 2017). We found 
statistically significant interactions (p-value  <  0.10) for child’s sex 
only and presented all results for boys and girls separately. 
To correct for multiple hypothesis testing, each p-value was com-
pared with a threshold defined as 0.05 divided by the effective number 
of independent tests estimated based on the correlation structure be-
tween the exposures (p-value threshold of 0.0098) (Li et al., 2012). To 
maintain statistical power and reduce bias related to missing data on 
covariates, we performed multiple imputation according to the Markov 
Chain Monte Carlo method. The percentage of missing values for cov-
ariates ranged from 0 to 22.7%. Covariates were used as predictor 
variables and imputed when necessary, while metabolic risk factors 
were used as predictor variables only. In addition, birth weight, ge-
stational age at birth, blood pressure at 10 years old and heart fre-
quency at 10 years old were used as predictor variables. Ten imputed 
datasets were created and no substantial differences were found be-
tween the original and imputed datasets. We present results based on 
pooled imputed datasets. All statistical analyses were performed using 
the Statistical Package of Social Sciences version 25.0 for Windows 
(SPSS Inc., Chicago, IL, USA). 
3. Results 
3.1. Participant characteristics 
Table 2 shows participant characteristics for the total group and for 
boys and girls separately. Non-response analyses showed that non- 
participants tended to have higher urine concentrations of some 
phthalates, were younger, lower educated and less likely to consume 
alcohol during pregnancy (Supplemental Tables S3 and S4). 
3.2. Maternal phthalate urine concentrations and childhood lipid profiles 
Table 3 shows that among boys an IQR increase in natural log- 
transformed third trimester maternal urine phthalic acid concentrations 
was associated with 0.20 (95% Confidence Interval (CI) 0.07; 0.34) SDS 
higher natural log transformed triglyceride concentrations (basic 
models are presented in Supplemental Table S5). This association was 
also present in the mutually adjusted model (Supplemental Table S6). 
The associations of higher overall mean maternal DEHP and overall 
mean maternal DNOP urine concentrations with higher triglycerides 
concentrations among boys did not remain significant after multiple 
testing adjustment (Table 3 and Supplemental Table S7). Similarly, the 
associations among girls of higher second trimester maternal phthalic 
acid urine concentrations with lower triglyceride concentrations in both 
the adjusted and mutually adjusted model and the association of higher 
third trimester maternal DNOP urine concentrations with higher nat-
ural log transformed triglyceride concentrations did not remain sig-
nificant after multiple testing adjustment (Table 3 and Supplemental 
Table S6). Maternal phthalate urine concentrations were not associated 
with cholesterol concentrations among boys or girls. 
3.3. Maternal bisphenol urine concentrations and childhood lipid profiles 
Among boys, maternal bisphenol urine concentrations were not 
associated with childhood total or LDL cholesterol concentrations 
(Supplemental Table S8). The associations of higher first and third 
trimester maternal BPF urine concentrations with higher HDL-choles-
terol and triglycerides concentrations, respectively, among boys did not 
remain significant after correction for multiple testing (Table 4). Higher 
natural log-transformed overall mean maternal bisphenol and BPA 
urine concentrations were associated with lower natural log trans-
formed triglyceride concentrations among girls, although these asso-
ciations did not remain significant after correction for multiple testing 
(Supplemental Table S7). Maternal bisphenol urine concentrations were 
not associated with total or HDL-, or LDL-cholesterol concentrations 
among girls (Table 4). No associations were found in the mutually 
adjusted model (Supplemental Table S9). 
3.4. Maternal phthalate urine concentrations and childhood glucose 
metabolism 
Among boys, after adjustment for confounders, an IQR higher 
second trimester and overall mean maternal HMWP and DEHP urine 
concentrations was associated with a 0.19 (95% CI 0.31–0.07), 0.18 
(95% CI 0.30–0.06), 0.18 (95% CI 0.31–0.06), 0.19 (95% CI 0.31–0.07) 
SDS lower glucose concentrations (Table 5 and Supplemental Table 
S10, basic models are presented in Supplemental Table S11). In the 
mutually adjusted model, these associations were attenuated towards 
non-significance (Supplemental Table S12). Maternal phthalate urine 
concentrations were not associated with insulin concentrations during 
childhood (Table 5). When including glucose concentrations in the 
model, maternal phthalate urine concentrations were again not asso-
ciated with insulin concentrations during childhood (Supplemental 
Table S13). 
3.5. Maternal bisphenol urine concentrations and childhood glucose 
metabolism 
Among boys, an IQR higher natural log-transformed third trimester 
maternal BPF urine concentrations was associated with 0.22 (95% CI 
0.35; 0.09) and 0.19 (95% CI 0.32; 0.05) SDS lower natural log trans-
formed insulin and glucose concentrations (Table 6, basic models are 
presented in Supplemental Table S14). The association of third trime-
ster maternal BPF urine concentrations with glucose concentrations and 
with insulin concentrations when corrected for glucose concentrations 
did not remain after multiple testing adjustment (Supplemental Table 
S15). The associations of higher first trimester maternal BPS urine 
concentrations with lower natural log transformed insulin and glucose 
concentrations among boys did not remain after adjustment for mul-
tiple testing (Table 6). In the fully adjusted and mutually adjusted 
model, among boys higher third trimester total bisphenol maternal 
urine concentrations was associated with lower natural log transformed 
insulin concentrations, although these associations did not remain after 
correction for multiple testing (Table 6 and Supplemental Table S16). 
Among girls, maternal bisphenol urine concentrations were not asso-
ciated with insulin or glucose concentrations (Table 6). 
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3.6. Maternal phthalate and bisphenol urine concentrations and risk of 
adverse cardio-metabolic risk factors 
An IQR increase in the natural log transformed third trimester 
maternal phthalic acid concentrations was associated with an increased 
triglycerides concentration among boys (Odds Ratio (OR) 1.67 (95% CI 
1.20; 2.31)) (Supplemental Table S17). An IQR increase in the natural 
log transformed third trimester maternal DNOP concentrations was 
associated with high triglycerides concentrations among girls (OR 1.62 
(95% CI 1.21; 2.18)). Among boys, an IQR increase in the natural log 
transformed third trimester maternal total bisphenol urine concentra-
tions was associated with lower insulin concentrations (OR 0.64 (95% 
CI 0.46; 0.90)) (Supplemental Table S18). 
4. Discussion 
4.1. Main findings 
In this population-based prospective cohort study, we observed that 
higher third trimester fetal exposure to phthalic acid is associated with 
higher non-fasting triglycerides concentrations among boys, while we 
observed no association of fetal exposure to phthalates with other lipid 
concentrations during childhood. Maternal bisphenol urine concentra-
tions were not associated with non-fasting lipid concentrations during 
childhood. Fetal exposure to phthalates was not associated with non- 
fasting insulin concentrations at 10 years old. Higher second trimester 
and overall mean HMWP and DEHP urine concentrations were asso-
ciated with lower non-fasting glucose concentrations among boys. 
Higher third trimester maternal urine BPF concentrations were also 
associated with lower non-fasting insulin concentrations among boys. 
4.2. Interpretation of main findings 
Exposure to phthalates and bisphenols is ubiquitous. Previous an-
imal and cross-sectional human studies have suggested associations of 
higher exposure to phthalates and bisphenols with adverse lipid and 
glucose metabolism (Li et al., 2014; Lee et al., 2016). However, results 
from the few prospective studies in humans are inconsistent (Vafeiadi 
et al., 2016, 2018; Perng et al., 2017; Watkins et al., 2016). Fetal ex-
posure to endocrine disruptors such as phthalates and bisphenols may 
lead to developmental metabolic adaptations, which could have long 
term consequences. In the current study, we examined the associations 
of maternal urine phthalate and bisphenol concentrations during 
pregnancy with non-fasting lipids, glucose, and insulin concentrations 
at school age. 
The associations of fetal phthalate or bisphenol exposure with lipid 
concentrations during childhood have been studied in three prospective 
human studies (Vafeiadi et al., 2016, 2018; Perng et al., 2017). In a 
study among 260 mother–child pairs, maternal third trimester urine 
monoethylphthalate (mEP) concentrations were inversely associated 
with non-fasting HDL-cholesterol concentrations at 4 years, but not at 
6 years (Vafeiadi et al., 2018). No associations were found between 
maternal phthalate concentrations and total cholesterol concentrations 
in childhood (Vafeiadi et al., 2018). Among 235 mothers from the same 
cohort, no associations were observed for maternal urine BPA con-
centrations with non-fasting blood concentrations of total cholesterol 
and HDL-cholesterol among 4-year-old children (Vafeiadi et al., 2016). 
In another study among 227 mother–child pairs, no consistent asso-
ciations were observed for the pregnancy-averaged maternal urine 
phthalate and BPA concentrations with fasting triglycerides, total 
cholesterol, HDL-cholesterol and calculated LDL-cholesterol among 
8–14-year-old children (Perng et al., 2017). In the present study, higher 
Table 2 
Characteristics of mothers and their children.       
Total group Boys Girls 
n = 757 n = 382 (50.5%) n = 375 (49.5%)  
Maternal characteristics    
Age at enrolment, mean (SD) (years) 31.0 (4.6) 31.1 (4.5) 30.9 (4.7) 
Parity, n (%)    
Nullipara 464 (61.6%) 232 (60.9%) 232 (62.4%) 
Multipara 289 (38.4%) 149 (39.1%) 140 (37.6%) 
Ethnicity, n (%)    
European 478 (63.6%) 245 (64.5%) 233 (62.6%) 
Non-European 274 (36.4%) 135 (35.5%) 139 (37.4%) 
Education, n (%)    
Low 52 (7.1%) 26 (7.0%) 26 (7.2%) 
Middle 286 (39.0%) 141 (37.8%) 145 (40.2%) 
High 396 (54.0%) 206 (55.2%) 190 (52.6%) 
Pre-pregnancy BMI, median (95% range) (kg/m2) 22.7 (18.6–34.7) 22.6 (18.5–34.4) 22.8 (18.6–35.1) 
Maternal diet quality score, mean (SD)a 7.9 (1.5) 7.9 (1.6) 7.9 (1.4) 
Folic acid supplementation, n (%), yes 503 (82.2%) 259 (83.8%) 244 (80.5%) 
Smoking during pregnancy, n (%), yes 165 (23.9%) 81 (23.6%) 84 (24.1%) 
First trimester, n (%), yes 104 (20.7%) 67 (20.1%) 73 (21.4%) 
Second trimester, n (%), yes 75 (11.3%) 35 (10.4%) 40 (12.3%) 
Third trimester, n (%), yes 68 (10.5%) 36 (10.7%) 32 (10.2%) 
Alcohol consumption during pregnancy (any), n (%), yes 419 (61.2%) 221 (64.8%) 198 (57.6%) 
First trimester, n (%), yes 361 (53.6%) 194 (57.7%) 167 (49.4%) 
Second trimester, n (%), yes 251 (38.1%) 133 (40.2%) 118 (36.1%) 
Third trimester, n (%), yes 256 (39.7%) 147 (44.3%) 109 (34.8%) 
Child characteristics       
Age, mean (SD) (years) 9.7 (0.2) 9.7 (0.3) 9.7 (0.2) 
BMI, median (95% range) (kg/m2) 16.8 (14.0–25.0) 16.6 (13.9–24.1) 17.1 (14.0–25.5) 
Triglycerides, median (95% range) (mmol/L) 1.0 (0.4–2.5) 0.9 (0.4–2.6) 1.0 (0.5–2.3) 
Total cholesterol, mean (SD) (mmol/L) 4.3 (0.6) 4.2 (0.6) 4.4 (0.6) 
HDL cholesterol, mean (SD) (mmol/L) 1.5 (0.3) 1.5 (0.3) 1.4 (0.3) 
LDL cholesterol, mean (SD) (mmol/L) 2.3 (0.6) 2.2 (0.6) 2.4 (0.6) 
Insulin, median (95% range) (pmol/L) 198.9 (37.5–671.0) 193.3 (31.5–571.0) 207.4 (38.5–804.6) 
Glucose, mean (SD) (mmol/L) 5.5 (0.9) 5.5 (0.9) 5.4 (0.9) 
Values represent mean (SD), median (95% range) or number of subjects (valid %). aAs based on the food frequency questionnaire filled out in early pregnancy.  
C.M. Sol, et al.   Environment International 144 (2020) 106063
5
Ta
bl
e 3
 
As
so
cia
tio
ns
 of
 m
ate
rn
al 
ur
ina
ry
 ph
th
ala
te 
co
nc
en
tra
tio
n d
ur
ing
 pr
eg
na
nc
y w
ith
 ch
ild
ho
od
 li
pid
 pr
ofi
le 
at 
10
 ye
ars
 st
rat
ifi
ed
 fo
r b
oy
s a
nd
 gi
rls
.   
    
    
    
   
M
ea
su
re
s o
f l
ip
id
 p
ro
fil
e a
t 1
0 
ye
ar
s (
in
 st
an
da
rd
 d
ev
iat
io
n 
sc
or
es
, 9
5%
 co
nfi
de
nc
e i
nt
er
va
l) 
  
Tr
igl
yc
er
id
es
 
To
ta
l c
ho
les
te
ro
l 
HD
L c
ho
les
te
ro
l 
LD
L c
ho
les
te
ro
l 
Ex
po
su
re
 
Tr
im
es
te
r 
Bo
ys
 (n
 =
 38
1)
 
Gi
rls
 (n
 =
 37
5)
 
p-
va
lu
e f
or
 
in
te
r-a
cti
on
 
Bo
ys
 (n
 =
 38
2)
 
Gi
rls
 (n
 =
 37
5)
 
p-
va
lu
e f
or
 
in
te
r-a
cti
on
 
Bo
ys
 (n
 =
 38
0)
 
Gi
rls
 (n
 =
 37
5)
 
p-
va
lu
e f
or
 
in
te
r-a
cti
on
 
Bo
ys
 (n
 =
 37
9)
 
Gi
rls
 (n
 =
 37
5)
 
p-
va
lu
e f
or
 
in
te
r-a
cti
on
  
PA
 
Fir
st 
tri
me
ste
r 
−
0.0
1 
(−
0.1
4; 
0.1
1)
 
0.0
4 (
−
0.0
8; 
0.1
6)
  
0.5
7 
−
0.0
1 (
−
0.1
3; 
0.1
00
) 
0.0
4 (
−
0.0
9; 
0.1
7)
  
0.5
5 
0.0
0 (
−
0.1
2; 
0.1
3)
 
0.0
5 (
−
0.0
7; 
0.1
7)
  
0.4
2 
−
0.0
2 (
−
0.1
4; 
0.0
9)
 
0.0
1 (
−
0.1
2; 
0.1
4)
  
0.7
3  
Se
co
nd
 
tri
me
ste
r 
0.0
6 (
−
0.1
0; 
0.2
1)
 
−
0.1
4 (
−
0.2
7; 
 
−
0.0
0)
*  
0.0
6#
 
−
0.0
1 (
−
0.1
5; 
0.1
3)
 
−
0.0
4 
(−
0.1
9; 
0.1
1)
  
0.7
2 
0.0
1 (
−
0.1
5; 
0.1
6)
 
0.0
6 (
−
0.0
8; 
0.1
9)
  
0.4
2 
−
0.0
2 (
−
0.1
6; 
0.1
2)
 
−
0.0
2 
(−
0.1
7; 
0.1
2)
  
0.8
1  
Th
ird
 
tri
me
ste
r 
0.2
0 (
0.0
7; 
0.3
4)
† 
0.0
6 (
−
0.0
7; 
0.1
9)
  
0.1
2 
0.0
5 (
−
0.0
8; 
0.1
7)
 
0.0
7 (
−
0.0
8; 
0.2
1)
  
0.8
7 
−
0.1
1 (
−
0.2
4; 
0.0
3)
 
−
0.0
6 (
−
0.1
9; 
0.0
7)
  
0.4
2 
0.0
4 (
−
0.0
9; 
0.1
6)
 
0.0
8 (
−
0.0
6; 
0.2
2)
  
0.7
5 
LM
W
P 
Fir
st 
tri
me
ste
r 
−
0.1
1 
(−
0.2
5; 
0.0
2)
 
0.0
5 (
−
0.0
8; 
0.1
8)
  
0.0
9#
 
−
0.0
2 (
−
0.1
4; 
0.1
1)
 
0.0
9 (
−
0.0
5; 
0.2
3)
  
0.4
4 
0.0
8 (
−
0.0
5; 
0.2
1)
 
0.0
4 (
−
0.0
9; 
0.1
6)
  
0.7
9 
−
0.0
5 (
−
0.1
7; 
0.0
7)
 
0.0
6 (
−
0.0
8; 
0.2
0)
  
0.3
6  
Se
co
nd
 
tri
me
ste
r 
0.0
5 (
−
0.1
0; 
0.2
0)
 
−
0.1
1 (
−
0.2
5; 
0.0
3)
  
0.1
8 
−
0.0
5 (
−
0.1
9; 
0.0
9)
 
0.0
4 (
−
0.1
2; 
0.1
9)
  
0.4
5 
0.0
8 (
−
0.0
7; 
0.2
2)
 
0.0
5 (
−
0.0
9; 
0.1
8)
  
0.8
7 
−
0.1
1 (
−
0.2
5; 
0.0
3)
 
0.0
6 (
−
0.0
9; 
0.2
1)
  
0.1
4  
Th
ird
 
tri
me
ste
r 
0.1
5 (
−
0.0
1; 
0.3
0)
 
0.0
6 (
−
0.0
9; 
0.2
1)
  
0.4
4 
0.0
1 (
−
0.1
4; 
0.1
6)
 
0.0
7 (
−
0.1
0; 
0.2
3)
  
0.7
0 
−
0.0
9 (
−
0.2
4; 
0.0
7)
 
−
0.0
3 (
−
0.1
7; 
0.1
2)
  
0.4
3 
0.0
3 (
−
0.1
2; 
0.1
7)
 
0.0
6 (
−
0.1
0; 
0.2
3)
  
0.8
7 
HM
W
P 
Fir
st 
tri
me
ste
r 
0.0
8 (
−
0.0
4; 
0.2
0)
 
0.0
1 (
−
0.1
2; 
0.1
3)
  
0.3
5 
0.0
4 (
−
0.0
7; 
0.1
5)
 
−
0.0
0 
(−
0.1
4; 
0.1
3)
  
0.5
6 
−
0.0
1 (
−
0.1
3; 
0.1
1)
 
0.0
2 (
−
0.1
0; 
0.1
4)
  
0.4
6 
0.0
0 (
−
0.1
1; 
0.1
1)
 
−
0.0
1 
(−
0.1
4; 
0.1
3)
  
0.8
0  
Se
co
nd
 
tri
me
ste
r 
0.0
7 (
−
0.0
6; 
0.2
0)
 
−
0.1
0 (
−
0.2
2; 
0.0
2)
  
0.0
5#
 
−
0.0
1 (
−
0.1
3; 
0.1
1)
 
−
0.0
8 
(−
0.2
1; 
0.0
5)
  
0.4
3 
−
0.0
1 (
−
0.1
4; 
0.1
2)
 
0.0
0 (
−
0.1
2; 
0.1
2)
  
0.7
0 
−
0.0
2 (
−
0.1
4; 
0.1
0)
 
−
0.0
6 
(−
0.1
9; 
0.0
7)
  
0.5
7  
Th
ird
 
tri
me
ste
r 
0.1
2 (
−
0.0
1; 
0.2
5)
 
0.0
3 (
−
0.0
8; 
0.1
3)
  
0.1
8 
−
0.0
3 (
−
0.1
5; 
0.0
9)
 
−
0.0
2 
(−
0.1
4; 
0.0
9)
  
1.0
0 
−
0.0
1 (
−
0.1
4; 
0.1
1)
 
0.0
5 (
−
0.0
5; 
0.1
5)
  
0.4
3 
−
0.0
8 (
−
0.2
0; 
0.0
4)
 
−
0.0
7 
(−
0.1
8; 
0.0
4)
  
0.9
5 
DE
HP
 
Fir
st 
tri
me
ste
r 
0.0
9 (
−
0.0
3; 
0.2
2)
 
0.0
1 (
−
0.1
2; 
0.1
3)
  
0.2
8 
0.0
7 (
−
0.0
5; 
0.1
8)
 
−
0.0
1 
(−
0.1
4; 
0.1
3)
  
0.3
9 
−
0.0
1 (
−
0.1
3; 
0.1
1)
 
0.0
2 (
−
0.1
1; 
0.1
4)
  
0.5
5 
0.0
3 (
−
0.0
9; 
0.1
4)
 
−
0.0
1 
(−
0.1
4; 
0.1
3)
  
0.6
4  
Se
co
nd
 
tri
me
ste
r 
0.1
0 (
−
0.0
4; 
0.2
3)
 
−
0.1
1 (
−
0.2
4; 
0.0
2)
  
0.0
4*
 
−
0.0
0 (
−
0.1
3; 
0.1
2)
 
−
0.1
0 
(−
0.2
4; 
0.0
4)
  
0.3
0 
−
0.0
1 (
−
0.1
4; 
0.1
2)
 
0.0
0 (
−
0.1
3; 
0.1
3)
  
0.8
1 
−
0.0
2 (
−
0.1
4; 
0.1
0)
 
−
0.0
8 
(−
0.2
2; 
0.0
6)
  
0.5
3  
Th
ird
 
tri
me
ste
r 
0.1
2 (
−
0.0
1; 
0.2
5)
 
0.0
2 (
−
0.0
9; 
0.1
2)
  
0.1
7 
0.0
1 (
−
0.1
1; 
0.1
3)
 
−
0.0
3 
(−
0.1
5; 
0.0
9)
  
0.6
1 
−
0.0
1 (
−
0.1
3; 
0.1
2)
 
0.0
5 (
−
0.0
5; 
0.1
6)
  
0.5
0 
−
0.0
4 (
−
0.1
6; 
0.0
8)
 
−
0.0
8 
(−
0.1
9; 
0.0
3)
  
0.6
0 
DN
OP
 
Fir
st 
tri
me
ste
r 
0.1
1 (
−
0.0
0; 
0.2
2)
 
0.0
0 (
−
0.1
1; 
0.1
1)
  
0.1
3 
0.0
3 (
−
0.0
8; 
0.1
3)
 
0.0
2 (
−
0.1
0; 
0.1
4)
  
0.8
2 
−
0.0
2 (
−
0.1
2; 
0.0
9)
 
0.0
1 (
−
0.1
0; 
0.1
2)
  
0.6
3 
−
0.0
2 (
−
0.1
2; 
0.0
8)
 
0.0
2 (
−
0.1
0; 
0.1
4)
  
0.7
0  
Se
co
nd
 
tri
me
ste
r 
0.1
0 (
−
0.0
4; 
0.2
3)
 
−
0.0
1 (
−
0.1
3; 
0.1
1)
  
0.2
4 
−
0.0
4 (
−
0.1
6; 
0.0
8)
 
0.0
0 (
−
0.1
3; 
0.1
3)
  
0.6
6 
−
0.0
6 (
−
0.1
9; 
0.0
6)
 
−
0.0
4 (
−
0.1
5; 
0.0
8)
  
0.7
7 
−
0.0
4 (
−
0.1
6; 
0.0
8)
 
0.0
2 (
−
0.1
1; 
0.1
5)
  
0.5
1  
Th
ird
 
tri
me
ste
r 
0.0
4 (
−
0.0
8; 
0.1
7)
 
0.1
2 (
0.0
1; 
0.2
4)
*  
0.4
3 
−
0.0
9 (
−
0.2
0; 
0.0
3)
 
0.0
4 (
−
0.0
9; 
0.1
6)
  
0.1
3 
−
0.0
5 (
−
0.1
7; 
0.0
8)
 
−
0.0
7 (
−
0.1
8; 
0.0
5)
  
0.7
8 
−
0.1
0 (
−
0.2
2; 
0.0
2)
 
0.0
2 (
−
0.1
0; 
0.1
5)
  
0.1
3 
Va
lue
s a
re 
reg
res
sio
n 
co
effi
cie
nt
s (
95
% 
co
nfi
de
nc
e i
nt
erv
al)
 fr
om
 li
ne
ar 
reg
res
sio
n 
mo
de
ls 
th
at 
refl
ec
t t
he
 d
iff
ere
nc
e i
n 
ca
rd
iom
eta
bo
lic
 ri
sk
 fa
cto
rs 
in 
SD
S 
for
 a
n 
int
erq
ua
rti
le 
ran
ge
 in
cre
as
e i
n 
ea
ch
 n
atu
ral
 lo
g- 
tra
ns
for
me
d p
ht
ha
lat
e (
in 
µm
ol/
g c
rea
tin
ine
). 
Tr
igl
yc
eri
de
s a
re 
na
tu
ral
 lo
g t
ran
sfo
rm
ed
. M
od
el 
inc
lud
es 
ch
ild
’s 
ag
e a
nd
 se
x- 
an
d a
ge
-st
an
da
rd
ize
d b
od
y m
as
s i
nd
ex
 an
d m
ate
rn
al 
ag
e, 
ed
uc
ati
on
, p
ari
ty,
 et
hn
ici
ty,
 pr
e- 
pr
eg
na
nc
y b
od
y m
as
s i
nd
ex
, fo
lic
 ac
id 
su
pp
lem
en
t u
se,
 m
ate
rn
al 
die
t q
ua
lit
y s
co
re,
 al
co
ho
l c
on
su
mp
tio
n a
nd
 sm
ok
ing
 ha
bit
s (
sp
ec
ifi
ca
lly
 in
 ea
rly
, m
id 
an
d l
ate
 pr
eg
na
nc
y)
. P
-va
lue
s f
or
 in
ter
ac
tio
n o
f s
ex
 ar
e p
res
en
ted
. 
# p
-va
lue
  <
  0
.10
; *
 p-
va
lue
  <
  0
.05
; †
 Si
gn
ifi
ca
nt
 af
ter
 co
rre
cti
on
 fo
r m
ult
ipl
e t
est
ing
 (p
-va
lue
 th
res
ho
ld 
of 
0.0
09
8)
. 
DE
HP
, d
i-2
-et
hy
lhe
xy
lph
th
ala
te;
 D
NO
P, 
di-
n-o
cty
lph
th
ala
te;
 H
MW
P, 
hig
h 
mo
lec
ula
r w
eig
ht
 ph
th
ala
te;
 LM
W
P, 
low
 m
ole
cu
lar
 w
eig
ht
 ph
th
ala
te;
 P
A,
 ph
th
ali
c a
cid
; S
DS
, s
tan
da
rd
 de
via
tio
n s
co
res
.  
C.M. Sol, et al.   Environment International 144 (2020) 106063
6
Ta
bl
e 4
 
As
so
cia
tio
ns
 of
 m
ate
rn
al 
ur
ina
ry
 bi
sp
he
no
l c
on
ce
nt
rat
ion
 du
rin
g p
reg
na
nc
y w
ith
 ch
ild
ho
od
 li
pid
 pr
ofi
le 
at 
10
 ye
ars
 st
rat
ifi
ed
 fo
r b
oy
s a
nd
 gi
rls
.   
    
    
    
   
M
ea
su
re
s o
f l
ip
id
 p
ro
fil
e a
t 1
0 
ye
ar
s (
in
 st
an
da
rd
 d
ev
iat
io
n 
sc
or
es
, 9
5%
 co
nfi
de
nc
e i
nt
er
va
l) 
  
Tr
igl
yc
er
id
es
 
To
ta
l c
ho
les
te
ro
l 
HD
L c
ho
les
te
ro
l 
LD
L c
ho
les
te
ro
l 
Ex
po
su
re
 
Tr
im
es
te
r 
Bo
ys
 (n
 =
 38
1)
 
Gi
rls
 (n
 =
 37
5)
 
p-
va
lu
e f
or
 
in
te
r-a
cti
on
 
Bo
ys
 (n
 =
 38
2)
 
Gi
rls
 (n
 =
 37
5)
 
p-
va
lu
e f
or
 
in
te
r-a
cti
on
 
Bo
ys
 (n
 =
 38
0)
 
Gi
rls
 (n
 =
 37
5)
 
p-
va
lu
e f
or
 
in
te
r-a
cti
on
 
Bo
ys
 (n
 =
 37
9)
 
Gi
rls
 (n
 =
 37
5)
 
p-
va
lu
e f
or
 
in
te
r-a
cti
on
  
BP
 
Fir
st 
tri
me
ste
r 
−
0.0
4 (
−
0.1
9; 
0.1
1)
 
−
0.0
9 (
−
0.2
1; 
0.0
3)
 
0.6
0 
0.0
0 (
−
0.1
4; 
0.1
4)
 
−
0.0
3 (
−
0.1
6; 
0.1
0)
 
0.6
8 
0.0
8 (
−
0.0
7; 
0.2
2)
 
0.0
5 (
−
0.0
7; 
0.1
6)
 
0.7
2 
−
0.0
2 (
−
0.1
5; 
0.1
2)
 
−
0.0
2 (
−
0.1
5; 
0.1
1)
 
0.9
5  
Se
co
nd
 
tri
me
ste
r 
0.0
6 (
−
0.0
7; 
0.1
9)
 
−
0.0
9 (
−
0.2
2; 
0.0
4)
 
0.1
1 
−
0.0
0 
(−
0.1
2; 
0.1
2)
 
−
0.0
2 (
−
0.1
6; 
0.1
2)
 
0.8
9 
0.0
0 (
−
0.1
3; 
0.1
3)
 
0.0
5 (
−
0.0
8; 
0.1
7)
 
0.5
6 
−
0.0
3 (
−
0.1
5; 
0.0
9)
 
−
0.0
2 (
−
0.1
5; 
0.1
2)
 
0.8
9  
Th
ird
 
tri
me
ste
r 
0.0
3 (
−
0.1
0; 
0.1
6)
 
−
0.0
4 (
−
0.1
7; 
0.0
9)
 
0.3
8 
0.0
1 (
−
0.1
1; 
0.1
3)
 
−
0.0
5 (
−
0.1
9; 
0.0
9)
 
0.5
6 
0.0
3 (
−
0.1
0; 
0.1
5)
 
0.0
4 (
−
0.0
9; 
0.1
6)
 
0.8
9 
−
0.0
0 (
−
0.1
2; 
0.1
1)
 
−
0.0
6 (
−
0.2
0; 
0.0
8)
 
0.7
1 
BP
A 
Fir
st 
tri
me
ste
r 
0.0
1 (
−
0.1
4; 
0.1
6)
 
−
0.1
0 (
−
0.2
2; 
0.0
2)
 
0.2
3 
−
0.0
3 
(−
0.1
7; 
0.1
1)
 
0.0
3 (
−
0.1
0; 
0.1
7)
 
0.6
5 
0.0
5 (
−
0.1
0; 
0.2
0)
 
0.0
7 (
−
0.0
5; 
0.1
9)
 
0.8
8 
−
0.0
6 (
−
0.2
0; 
0.0
8)
 
0.0
4 (
−
0.0
9; 
0.1
7)
 
0.3
0  
Se
co
nd
 
tri
me
ste
r 
0.0
6 (
−
0.0
7; 
0.1
9)
 
−
0.0
9 (
−
0.2
2; 
0.0
3)
 
0.1
1 
−
0.0
1 
(−
0.1
2; 
0.1
1)
 
−
0.0
1 (
−
0.1
5; 
0.1
3)
 
0.9
9 
−
0.0
1 (
−
0.1
4; 
0.1
1)
 
0.0
6 (
−
0.0
7; 
0.1
8)
 
0.3
6 
−
0.0
2 (
−
0.1
4; 
0.1
0)
 
−
0.0
1 (
−
0.1
5; 
0.1
2)
 
0.9
4  
Th
ird
 
tri
me
ste
r 
0.0
3 (
−
0.1
0; 
0.1
5)
 
−
0.0
5 (
−
0.1
8; 
0.0
7)
 
0.3
5 
0.0
4 (
−
0.0
8; 
0.1
5)
 
−
0.0
6 (
−
0.2
0; 
0.0
7)
 
0.2
5 
0.0
3 (
−
0.0
9; 
0.1
5)
 
0.0
0 (
−
0.1
2; 
0.1
2)
 
0.5
9 
0.0
3 (
−
0.0
9; 
0.1
4)
 
−
0.0
5 (
−
0.1
8; 
0.0
8)
 
0.4
7 
BP
S 
Fir
st 
tri
me
ste
r 
0.0
5 (
−
0.0
7; 
0.1
8)
 
0.0
2 (
−
0.0
9; 
0.1
3)
 
0.6
7 
0.0
6 (
−
0.0
6; 
0.1
7)
 
−
0.0
9 (
−
0.2
1; 
0.0
3)
 
0.0
9#
 
−
0.1
0 (
−
0.2
2; 
0.0
2)
 
−
0.0
1 
(−
0.1
2; 
0.1
1)
 
0.2
1 
0.1
1 (
−
0.0
1; 
0.2
2)
 
−
0.1
0 (
−
0.2
2; 
0.0
2)
 
0.0
2*
  
Se
co
nd
 
tri
me
ste
r 
0.0
4 (
−
0.1
0; 
0.1
7)
 
−
0.0
1 (
−
0.1
2; 
0.1
1)
 
0.6
8 
0.0
4 (
−
0.0
9; 
0.1
6)
 
−
0.0
1 (
−
0.1
4; 
0.1
3)
 
0.7
8 
0.0
9 (
−
0.0
4; 
0.2
2)
 
−
0.0
3 
(−
0.1
5; 
0.0
9)
 
0.0
9#
 
−
0.0
5 (
−
0.1
8; 
0.0
7)
 
0.0
3 (
−
0.1
0; 
0.1
5)
 
0.2
4  
Th
ird
 
tri
me
ste
r 
NA
 
NA
 
NA
 
NA
 
NA
 
NA
 
NA
 
NA
 
NA
 
NA
 
NA
 
NA
 
BP
F 
Fir
st 
tri
me
ste
r 
−
0.0
8 (
−
0.2
3; 
0.0
7)
 
−
0.0
6 (
−
0.1
9; 
0.0
7)
 
0.7
8 
0.0
8 (
−
0.0
6; 
0.2
1)
 
0.0
2 (
−
0.1
2; 
0.1
6)
 
0.8
1 
0.1
8 (
0.0
4; 
0.3
2)
* 
0.0
2 (
−
0.1
1; 
0.1
5)
 
0.1
4 
0.0
1 (
−
0.1
3; 
0.1
4)
 
0.0
4 (
−
0.1
0; 
0.1
8)
 
0.5
6  
Se
co
nd
 
tri
me
ste
r 
NA
 
NA
 
NA
 
NA
 
NA
 
NA
 
NA
 
NA
 
NA
 
NA
 
NA
 
NA
  
Th
ird
 
tri
me
ste
r 
0.1
5 (
0.0
; 
0.2
9)
* 
0.0
3 (
−
0.1
0; 
0.1
7)
 
0.2
2 
0.0
4 (
−
0.0
9; 
0.1
7)
 
0.0
3 (
−
0.1
1; 
0.1
8)
 
0.7
4 
−
0.0
2 (
−
0.1
6; 
0.1
2)
 
−
0.0
1 
(−
0.1
4; 
0.1
2)
 
0.9
4 
−
0.0
1 (
−
0.1
4; 
0.1
1)
 
0.0
3 (
−
0.1
1; 
0.1
7)
 
0.4
5 
Va
lue
s a
re 
reg
res
sio
n 
co
effi
cie
nt
s (
95
% 
co
nfi
de
nc
e i
nt
erv
al)
 fr
om
 li
ne
ar 
reg
res
sio
n 
mo
de
ls 
th
at 
refl
ec
t t
he
 d
iff
ere
nc
e i
n 
ca
rd
iom
eta
bo
lic
 ri
sk
 fa
cto
rs 
in 
SD
S 
for
 a
n 
int
erq
ua
rti
le 
ran
ge
 in
cre
as
e i
n 
ea
ch
 n
atu
ral
 lo
g- 
tra
ns
for
me
d b
isp
he
no
l (
in 
µm
ol/
g c
rea
tin
ine
). 
Tr
igl
yc
eri
ds
 ar
e n
atu
ral
 lo
g t
ran
sfo
rm
ed
. M
od
el 
inc
lud
es 
ch
ild
’s 
ag
e a
nd
 se
x- 
an
d a
ge
-st
an
da
rd
ize
d 
bo
dy
 m
as
s i
nd
ex
 an
d 
ma
ter
na
l a
ge
, e
du
ca
tio
n, 
pa
rit
y, 
eth
nic
ity
, p
re-
 
pr
eg
na
nc
y b
od
y m
as
s i
nd
ex
, f
oli
c a
cid
 su
pp
lem
en
t u
se,
 m
ate
rn
al 
die
t q
ua
lit
y s
co
re,
 al
co
ho
l c
on
su
mp
tio
n 
an
d 
sm
ok
ing
 h
ab
its
 (s
pe
cifi
ca
lly
 in
 ea
rly
, m
id 
an
d 
lat
e p
reg
na
nc
y)
. P
-va
lue
s f
or
 in
ter
ac
tio
n 
of 
ch
ild
’s 
sex
 ar
e 
pr
ese
nt
ed
. 
# p
-va
lue
  <
  0
.10
; *
 p-
va
lue
  <
  0
.05
; †
 Si
gn
ifi
ca
nt
 af
ter
 co
rre
cti
on
 fo
r m
ult
ipl
e t
est
ing
 (p
-va
lue
 th
res
ho
ld 
of 
0.0
09
8)
. 
BP
, b
isp
he
no
ls;
 B
PA
, b
isp
he
no
l A
; B
PF
, b
isp
he
no
l F
; B
PS
, b
isp
he
no
l S
; N
A:
 no
t a
pp
lic
ab
le 
du
e t
o  
>
  8
0%
 of
 co
nc
en
tra
tio
ns
 be
low
 li
mi
t o
f d
ete
cti
on
; S
DS
, s
tan
da
rd
 de
via
tio
n s
co
res
.  
C.M. Sol, et al.   Environment International 144 (2020) 106063
7
Ta
bl
e 5
 
As
so
cia
tio
ns
 of
 m
ate
rn
al 
ur
ina
ry
 ph
th
ala
te 
co
nc
en
tra
tio
n d
ur
ing
 pr
eg
na
nc
y w
ith
 ch
ild
ho
od
 gl
uc
os
e m
eta
bo
lis
m 
at 
10
 ye
ars
 st
rat
ifi
ed
 fo
r b
oy
s a
nd
 gi
rls
.   
    
    
 
M
ea
su
re
s o
f g
lu
co
se
 m
et
ab
ol
ism
 at
 1
0 
ye
ar
s (
in
 st
an
da
rd
 d
ev
iat
io
n 
sc
or
es
, 9
5%
 co
nfi
de
nc
e i
nt
er
va
l) 
  
In
su
lin
 
Gl
uc
os
e 
Ex
po
su
re
 
Tr
im
es
te
r 
Bo
ys
 (n
 =
 38
0)
 
Gi
rls
 (n
 =
 37
3)
 
p-
va
lu
e f
or
 in
te
ra
cti
on
 
Bo
ys
 (n
 =
 38
2)
 
Gi
rls
 (n
 =
 37
4)
 
p-
va
lu
e f
or
 in
te
ra
cti
on
  
PA
 
Fir
st 
tri
me
ste
r 
−
0.0
2 (
−
0.1
4; 
0.1
0)
 
0.0
2 (
−
0.1
1; 
0.1
5)
 
0.4
9 
−
0.0
5 
(−
0.1
7; 
0.0
7)
 
0.0
4 (
−
0.1
0; 
0.1
7)
 
0.5
5  
Se
co
nd
 tr
im
est
er 
−
0.0
6 (
−
0.2
1; 
0.0
8)
 
−
0.0
1 (
−
0.1
5; 
0.1
4)
 
0.4
8 
−
0.1
5 
(−
0.3
0; 
−
0.0
1)
* 
0.0
2 (
−
0.1
3; 
0.1
6)
 
0.1
5  
Th
ird
 tr
im
est
er 
0.0
1 (
−
0.1
2; 
0.1
4)
 
0.0
3 (
−
0.1
1; 
0.1
6)
 
0.8
6 
−
0.0
3 
(−
0.1
6; 
0.1
0)
 
−
0.0
2 
(−
0.1
6; 
0.1
2)
 
0.8
5 
LM
W
P 
Fir
st 
tri
me
ste
r 
0.0
2 (
−
0.1
1; 
0.1
4)
 
0.0
5 (
−
0.0
9; 
0.1
9)
 
0.5
3 
−
0.0
1 
(−
0.1
4; 
0.1
2)
 
−
0.0
8 
(−
0.2
2; 
0.0
5)
 
0.3
0  
Se
co
nd
 tr
im
est
er 
0.0
5 (
−
0.0
9; 
0.1
9)
 
−
0.0
4 (
−
0.1
8; 
0.1
1)
 
0.6
0 
0.0
2 (
−
0.1
3; 
0.1
6)
 
−
0.0
5 
(−
0.2
0; 
0.1
0)
 
0.4
3  
Th
ird
 tr
im
est
er 
0.0
0 (
−
0.1
5; 
0.1
5)
 
0.0
5 (
−
0.1
1; 
0.2
1)
 
0.6
1 
−
0.0
3 
(−
0.1
8; 
0.1
2)
 
−
0.0
4 
(−
0.2
1; 
0.1
2)
 
0.6
4 
HM
W
P 
Fir
st 
tri
me
ste
r 
−
0.0
2 (
−
0.1
3; 
0.0
9)
 
0.0
6 (
−
0.0
7; 
0.1
9)
 
0.2
9 
−
0.1
1 
(−
0.2
2; 
0.0
0)
 
0.0
1 (
−
0.1
3; 
0.1
4)
 
0.2
5  
Se
co
nd
 tr
im
est
er 
−
0.1
0 (
−
0.2
2; 
0.0
2)
 
0.0
2 (
−
0.1
1; 
0.1
5)
 
0.0
8*
 
−
0.1
9 
(−
0.3
1; 
−
0.0
7)
† 
0.0
3 (
−
0.1
0; 
0.1
6)
 
0.0
2*
  
Th
ird
 tr
im
est
er 
−
0.0
8 (
−
0.2
0; 
0.0
4)
 
0.0
2 (
−
0.0
9; 
0.1
3)
 
0.2
5 
−
0.1
0 
(−
0.2
2; 
0.0
3)
 
0.0
3 (
−
0.0
9; 
0.1
4)
 
0.2
2 
DE
HP
 
Fir
st 
tri
me
ste
r 
−
0.0
3 (
−
0.1
4; 
0.0
9)
 
0.0
6 (
−
0.0
8; 
0.1
9)
 
0.3
3 
−
0.1
1 
(−
0.2
3; 
0.0
0)
 
0.0
1 (
−
0.1
3; 
0.1
4)
 
0.2
4  
Se
co
nd
 tr
im
est
er 
−
0.1
1 (
−
0.2
4; 
0.0
2)
 
0.0
1 (
−
0.1
2; 
0.1
5)
 
0.1
2 
−
0.1
8 
(−
0.3
1; 
−
0.0
6)
† 
0.0
4 (
−
0.1
0; 
0.1
8)
 
0.0
2*
  
Th
ird
 tr
im
est
er 
−
0.0
9 (
−
0.2
1; 
0.0
3)
 
0.0
2 (
−
0.0
9; 
0.1
3)
 
0.2
4 
−
0.1
0 
(−
0.2
3; 
0.0
2)
 
0.0
3 (
−
0.0
8; 
0.1
5)
 
0.1
9 
DN
OP
 
Fir
st 
tri
me
ste
r 
−
0.0
2 (
−
0.1
2; 
0.0
9)
 
0.0
3 (
−
0.0
9; 
0.1
5)
 
0.5
2 
−
0.0
7 
(−
0.1
8; 
0.0
3)
 
0.0
5 (
−
0.0
7; 
0.1
8)
 
0.1
5  
Se
co
nd
 tr
im
est
er 
−
0.0
4 (
−
0.1
6; 
0.0
8)
 
0.0
2 (
−
0.1
1; 
0.1
4)
 
0.4
2 
−
0.0
9 
(−
0.2
2; 
0.0
3)
 
0.0
5 (
−
0.0
8; 
0.1
8)
 
0.1
4  
Th
ird
 tr
im
est
er 
−
0.0
2 (
−
0.1
4; 
0.1
0)
 
0.0
3 (
−
0.0
9; 
0.1
5)
 
0.5
5 
−
0.0
8 
(−
0.2
0; 
0.0
4)
 
0.0
6 (
−
0.0
6; 
0.1
9)
 
0.1
0 
Va
lue
s a
re 
reg
res
sio
n 
co
effi
cie
nt
s (
95
% 
co
nfi
de
nc
e i
nt
erv
al)
 fr
om
 li
ne
ar 
reg
res
sio
n 
mo
de
ls 
th
at 
refl
ec
t t
he
 d
iff
ere
nc
e i
n 
glu
co
se 
me
tab
oli
sm
 in
 SD
S f
or
 an
 in
ter
qu
art
ile
 ra
ng
e i
nc
rea
se 
in 
ea
ch
 n
atu
ral
 lo
g-t
ran
sfo
rm
ed
 
ph
th
ala
te 
(in
 µm
ol/
g c
rea
tin
ine
). 
Ins
uli
n l
ev
els
 ar
e n
atu
ral
 lo
g t
ran
sfo
rm
ed
. M
od
el 
inc
lud
es 
ch
ild
’s 
ag
e a
nd
 ag
e- 
an
d s
ex
-st
an
da
rd
ize
d b
od
y m
as
s i
nd
ex
 an
d m
ate
rn
al 
ag
e, 
ed
uc
ati
on
, p
ari
ty,
 et
hn
ici
ty,
 pr
e-p
reg
na
nc
y b
od
y 
ma
ss 
ind
ex
, f
oli
c a
cid
 su
pp
lem
en
t u
se,
 m
ate
rn
al 
die
t q
ua
lit
y s
co
re,
 al
co
ho
l c
on
su
mp
tio
n a
nd
 sm
ok
ing
 h
ab
its
 (s
pe
cifi
ca
lly
 in
 ea
rly
, m
id 
an
d l
ate
 pr
eg
na
nc
y)
. P
-va
lue
s f
or
 in
ter
ac
tio
n o
f s
ex
 ar
e p
res
en
ted
. 
# p
-va
lue
  <
  0
.10
; *
 p-
va
lue
  <
  0
.05
; †
 Si
gn
ifi
ca
nt
 af
ter
 co
rre
cti
on
 fo
r m
ult
ipl
e t
est
ing
 (p
-va
lue
 th
res
ho
ld 
of 
0.0
09
8)
. 
DE
HP
, d
i-2
-et
hy
lhe
xy
lph
th
ala
te;
 D
NO
P, 
di-
n-o
cty
lph
th
ala
te;
 H
MW
P, 
hig
h 
mo
lec
ula
r w
eig
ht
 ph
th
ala
te;
 LM
W
P, 
low
 m
ole
cu
lar
 w
eig
ht
 ph
th
ala
te;
 P
A,
 ph
th
ali
c a
cid
; S
DS
, s
tan
da
rd
 de
via
tio
n s
co
res
.  
C.M. Sol, et al.   Environment International 144 (2020) 106063
8
third trimester maternal urine phthalic acid concentrations were asso-
ciated with higher non-fasting triglycerides concentrations among boys. 
Since phthalic acid is a common metabolite of all phthalates, the higher 
effect estimates for phthalic acid than for HMWP or DEHP metabolites 
could be explained by effects of metabolites of newer phthalates which 
were not measured separately but are included in the phthalic acid 
measurement. The only other study that investigated non-fasting tri-
glycerides concentrations after fetal exposure to phthalates in humans 
did not find any associations among all children and among boys and 
girls separately, which could be due to a power issue (Vafeiadi et al., 
2018). The association of higher maternal urine BPA concentrations 
with lower triglycerides concentrations among girls in the present study 
was not in line with our hypothesis, which was mainly based on the 
earlier reported association of higher BPA concentrations with in-
creased risk of cardiovascular disease (Lang et al., 2008). However, our 
observation was in line with results from a recent meta-analysis of 
cross-sectional human studies suggesting that higher BPA concentra-
tions were associated with lower triglycerides (Dunder et al., 2019). 
The associations of overall mean BPA concentrations with triglycerides 
in our study have to be interpreted with caution, due to the fact that 
they did not remain significant after correction for multiple testing and 
could thus be a chance finding. In the current study, no other associa-
tions of bisphenols with lipid concentrations were found. No previous 
longitudinal human studies looked into the association of these newer 
bisphenols such as BPS or BPF with lipid concentrations during child-
hood. Animal studies that investigated these associations found varying 
effects for specific bisphenols (Meng et al., 2018). These differences in 
associations could suggest distinct underlying mechanisms for different 
bisphenols and this urges further investigation of the newer bisphenols 
or trimester specific effects. 
The associations of fetal exposure to bisphenols with childhood 
glucose metabolism markers have also been studied in multiple animal 
studies, which in general showed tendencies for associations of higher 
fetal exposure to BPA with diabetogenic effects (Bano et al., 2019; 
Taylor et al., 2018). In humans, cross-sectional studies have also shown 
an association between higher exposure to several phthalates and dia-
betes (James-Todd et al., 2012). To our knowledge, among humans this 
association has only been studied in one prospective study (Watkins 
et al., 2016). In that study, a few sex- and pubertal status-dependent 
associations were observed of third trimester phthalate and BPA ex-
posures with C-peptide, a marker of insulin secretion, and fasting glu-
cose among 219 children at 8–14 years old (Watkins et al., 2016). More 
specifically, higher maternal total dibutylphthalate (DBP) and mono(3- 
carboxypropyl)-phthalate (mCPP) urine concentrations were associated 
with lower fasting glucose concentrations among pubertal boys, while 
higher maternal mEP urine concentrations were associated with lower 
C-peptide index among prepubertal girls (Watkins et al., 2016). No 
associations of fetal BPA with childhood metabolic outcomes were re-
ported (Watkins et al., 2016). In the current study, we observed that 
fetal exposure to HMWP and DEHP was associated with non-fasting 
glucose concentrations. This is partially in line with the previous study, 
that found that higher phthalate exposure was associated with lower 
glucose and insulin concentrations. The absence of an association of 
BPA with glucose and insulin concentrations in the current study is in 
line with the previous study (Watkins et al., 2016). Among boys, we 
observed an association between third trimester maternal BPF con-
centrations with lower insulin and glucose concentrations and between 
third trimester maternal BPA concentrations with lower insulin con-
centrations after correction for glucose. It is important to note that the 
association of higher third trimester maternal BPF concentrations with 
lower glucose concentrations among boys and the association of higher 
third trimester maternal BPA concentrations with lower insulin con-
centrations after correction for glucose among boys did not remain 
significant after correction for multiple testing and could thus be a 
chance finding, while it is in line with the lower insulin concentrations 
that were found. We cannot compare these association with previous Ta
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studies, as these effects of BPF were not previously assessed in humans. 
These results suggest that fetal exposure to bisphenols could be asso-
ciated with lower non-fasting glucose and insulin concentrations later 
in life, however, these results need to be replicated with fasting glucose 
and insulin levels to more accurately assess insulin sensitivity. 
In conclusion, our results add to the growing body of evidence that 
fetal exposure of specific phthalates and bisphenols could influence 
later metabolic health in humans. We cannot draw conclusions about 
causality due to the observational nature of this study. The effect esti-
mates observed in this study are small, but they are of interest from a 
public health perspective because of the widespread use of bisphenols 
and phthalates. 
4.3. Possible underlying mechanisms 
From animal studies it has been suggested that phthalates, via the 
PPARalpha-receptor, can increase HDL-cholesterol concentrations and 
decrease production of triglycerides by influencing lipid oxidation and 
fatty acid synthesis and can increase the uptake of triglycerides 
(Hayashi et al., 2011; Colin et al., 2013; Laplante et al., 2007). It is not 
clear whether these mechanisms are as important in humans as they are 
in animals. The discrepancy between the findings in human studies and 
animal studies might thus be based on an interspecies difference of 
unknown origin. This could also explain the absence of effect of most 
studied phthalates on lipid concentrations observed in this study. On 
the other hand, laboratory studies have found that phthalate metabo-
lites increase cytokine production and thus can lead to an adverse in-
flammatory environment (Jepsen et al., 2004). This could be the reason 
that higher exposure to phthalic acid was found to be associated with 
higher triglycerides concentrations among boys in this study. Specific 
phthalates have also been shown to affect insulin signaling (Rajagopal 
et al., 2019). 
It has been found that BPA could affect fatty acid and glucose me-
tabolism and it is thought that exposure to BPA alters the glucose-sti-
mulated insulin response (Ji et al., 2019; Stahlhut et al., 2018; Alonso- 
Magdalena et al., 2006). However, in this study fetal exposure to BPA 
was not associated with lipid concentrations or glucose metabolism at 
10 years old. In contrast to a previous study that suggested that BPF 
exposure could lead to hyperglycemia in zebrafish, we found that 
higher BPF concentrations during pregnancy were associated with 
lower insulin concentrations and not with higher glucose concentra-
tions in children at 10 years old (Zhao et al., 2018). 
Both phthalates and bisphenol A influence epigenetic regulatory 
mechanisms, which may need considerable time to lead to measurable 
changes in circulating biomarkers and this timing issue could possibly 
explain the discrepancies (Martinez-Ibarra et al., 2019; Somm et al., 
2009; Goodrich et al., 2016). It has even been suggested that exposure 
to bisphenols influences health in subsequent generations (Bansal et al., 
2019; Susiarjo et al., 2015). The relationship between exposure to en-
docrine disruptors and metabolic disturbances is potentially sex-specific 
(Miura et al., 2019). This could be due to sex-specific differences in 
PPAR-activity of phthalates and the estrogenic effect of BPA (Jalouli 
et al., 2003; Huang and Chen, 2017). In animals, epigenetic repro-
gramming is also considered a potential molecular mechanism that 
might underlie the sex-specific associations of the prenatal exposure to 
endocrine disruptors with metabolic outcomes later in life (McCabe 
et al., 2017; Neier et al., 2019). Further studies are needed to elucidate 
the underlying mechanisms of endocrine disruptors on lipid and glucose 
metabolism in humans specifically. 
4.4. Methodological considerations 
An important strength of this study is the population-based cohort 
design from fetal life onward, with repeated measurements of maternal 
phthalate and bisphenol concentrations. We also measured childhood 
lipid and glucose concentrations in a large number of mother–child 
pairs. Selection bias due to selective loss to follow-up would be of 
concern in any study if the associations of prenatal phthalate and bi-
sphenol concentrations with childhood lipid and glucose metabolism 
are different between participants and non-participants. This seems 
unlikely, but cannot be excluded with certainty, because the reported 
differences in ethnicity could influence diet and lifestyle choices which 
could influence the associations. Furthermore, we measured maternal 
phthalate and bisphenol urine concentrations once per trimester. It is 
possible that one urine sample per trimester does not accurately re-
present the concentration during the whole trimester because of the 
reported short biological half-lives of phthalates and bisphenols 
(Mattison et al., 2014; Braun et al., 2013). However, it has been found 
that a single urine sample reflects phthalate exposure up to three 
months (Hauser et al., 2004). Variability has also been reported to be 
biomarker specific, with strong correlations for LMWP metabolites and 
reasonable correlations for BPA and DEHP metabolites (Braun et al., 
2012; Mahalingaiah et al., 2008). In this study, we found moderate 
variability for phthalates and high variability for bisphenols during 
pregnancy. We also used the overall mean to partly correct for the re-
maining variability. These associations were comparable to the trime-
ster-specific associations. The main limitation of using a linear regres-
sion approach is that it does not take into account the association of the 
investigated exposure with other exposures. This could provide un-
reliable results if the exposures are highly correlated, which the ex-
posures are not (Supplemental Table S2). We used non-fasting blood 
samples collected at different times during the day depending on the 
time of visit. This could have led to non-differential misclassification of 
children and consequently an underestimation of the associations. 
However, previous studies in adults have shown that non-fasting blood 
lipid concentrations can accurately predict increased risks of cardio-
vascular events later in life and that semi-fasting insulin resistance is 
moderately correlated with fasting values (Langsted and Nordestgaard, 
2019; Hancox and Landhuis, 2011). We also assessed the association of 
phthalates and bisphenols with insulin, independent of glucose, to 
partially correct for the varying times since last meal and found com-
parable results. However, these results need to be replicated with non- 
fasting lipid, insulin and glucose concentrations in children. Future 
studies could also assess the effects of childhood exposure to phthalates 
and bisphenols on metabolic outcomes. Finally, we collected informa-
tion on many potential confounders, although, as in any observational 
study, residual confounding due to unmeasured variables might remain 
an issue. 
5. Conclusion 
Results from our population-based prospective cohort study suggest 
persisting effects of fetal exposure to phthalates and bisphenols on 
childhood lipid concentrations which could be sex specific. Future 
studies are needed for replication and exploring underlying mechan-
isms. 
6. Sources of financial support 
The general design of the Generation R Study is made possible by 
financial support from the Erasmus MC, University Medical Center, 
Rotterdam, the Netherlands, the Organization for Health Research and 
Development (ZonMw) and the Ministry of Health, Welfare and Sport. 
This study was supported by grant RO1- ES022972 and RO1-ES029779 
from the National Institutes of Health, USA. The content is solely the 
responsibility of the authors and does not represent the official views of 
the National Institutes of Health. This work was supported by the 
European Union’s Horizon 2020 research and innovation programme 
under grant agreement 874583 (ATHLETE Project). VWVJ received an 
additional grant from the European Research Council (ERC 
Consolidator Grant, ERC-2014-CoG-64916). 
C.M. Sol, et al.   Environment International 144 (2020) 106063
10
CRediT authorship contribution statement 
Chalana M. Sol: Methodology, Formal analysis, Writing - original 
draft. Susana Santos: Methodology, Formal analysis, Writing - original 
draft. Liesbeth Duijts: Writing - review & editing. Alexandros G. 
Asimakopoulos: Investigation, Writing - review & editing. Maria-Pilar 
Martinez-Moral: Investigation, Writing - review & editing. 
Kurunthachalam Kannan: Investigation, Writing - review & editing. 
Vincent W.V. Jaddoe: Conceptualization, Resources, Supervision, 
Funding acquisition, Writing - review & editing. Leonardo Trasande: 
Conceptualization, Resources, Supervision, Funding acquisition, 
Writing - review & editing. 
Declaration of Competing Interest 
The authors declare that they have no known competing financial 
interests or personal relationships that could have appeared to influ-
ence the work reported in this paper. 
Acknowledgments 
We gratefully acknowledge the contribution of the participating 
children, their mothers, general practitioners, hospitals, midwives, and 
pharmacies in Rotterdam. 
Appendix A. Supplementary material 
Supplementary data to this article can be found online at https:// 
doi.org/10.1016/j.envint.2020.106063. 
References 
Alonso-Magdalena, P., Morimoto, S., Ripoll, C., et al., 2006. The estrogenic effect of bi-
sphenol A disrupts pancreatic beta-cell function in vivo and induces insulin re-
sistance. Environ. Health Perspect. 114, 106–112. 
Bano, U., Memon, S., Shahani, M.Y., et al., 2019. Epigenetic effects of in utero bisphenol A 
administration: Diabetogenic and atherogenic changes in mice offspring. Iran J. Basic 
Med. Sci. 22, 521–528. 
Bansal, A., Li, C., Xin, F., et al., 2019. Transgenerational effects of maternal bisphenol A 
exposure on offspring metabolic health. J. Dev. Orig. Health Dis. 10, 164–175. 
Braun, J.M., Smith, K.W., Williams, P.L., et al., 2012. Variability of urinary phthalate 
metabolite and bisphenol A concentrations before and during pregnancy. Environ. 
Health Perspect. 120, 739–745. 
Braun, J.M., Sathyanarayana, S., Hauser, R., 2013. Phthalate exposure and children's 
health. Curr. Opin. Pediatr. 25, 247–254. 
Colin, S., Briand, O., Touche, V., et al., 2013. Activation of intestinal peroxisome pro-
liferator-activated receptor-alpha increases high-density lipoprotein production. Eur. 
Heart J. 34, 2566–2574. 
Dolinoy, D.C., Huang, D., Jirtle, R.L., 2007. Maternal nutrient supplementation coun-
teracts bisphenol A-induced DNA hypomethylation in early development. Proc. Natl. 
Acad. Sci. U. S. A. 104, 13056–13061. 
Dunder, L., Lejonklou, M.H., Lind, P.M., et al., 2019. Urinary bisphenol A and serum 
lipids: a meta-analysis of six NHANES examination cycles (2003–2014). J. Epidemiol. 
Community Health 73, 1012–1019. 
Golestanzadeh, M., Riahi, R., Kelishadi, R., 2019. Association of exposure to phthalates 
with cardiometabolic risk factors in children and adolescents: a systematic review 
and meta-analysis. Environ. Sci. Pollut. Res. Int. 
Goodrich, J.M., Dolinoy, D.C., Sanchez, B.N., et al., 2016. Adolescent epigenetic profiles 
and environmental exposures from early life through peri-adolescence. Environ. 
Epigenet 2:dvw018. 
Gules, O., Yildiz, M., Naseer, Z., et al., 2019. Effects of folic acid on testicular toxicity 
induced by bisphenol-A in male Wistar rats. Biotech. Histochem. 94, 26–35. 
Hancox, R.J., Landhuis, C.E., 2011. Correlation between measures of insulin resistance in 
fasting and non-fasting blood. Diabetol. Metab. Syndr. 3, 23. 
Hauser, R., Meeker, J.D., Park, S., et al., 2004. Temporal variability of urinary phthalate 
metabolite levels in men of reproductive age. Environ. Health Perspect. 112, 
1734–1740. 
Hayashi, Y., Ito, Y., Yamagishi, N., et al., 2011. Hepatic peroxisome proliferator-activated 
receptor alpha may have an important role in the toxic effects of di(2-ethylhexyl) 
phthalate on offspring of mice. Toxicology 289, 1–10. 
Hornung, R.W., 1990. RL, Estimation of average concentration in the presence of non-
detectable values. Appl. Occup. Environ. Hyg. 5, 46–51. 
Huang, Q., Chen, Q., 2017. Mediating roles of PPARs in the effects of environmental 
chemicals on sex steroids. PPAR Res. 2017, 3203161. 
Jaddoe, V.W., van Duijn, C.M., Franco, O.H., et al., 2012. The Generation R Study: design 
and cohort update 2012. Eur. J. Epidemiol. 27, 739–756. 
Jalouli, M., Carlsson, L., Ameen, C., et al., 2003. Sex difference in hepatic peroxisome 
proliferator-activated receptor alpha expression: influence of pituitary and gonadal 
hormones. Endocrinology 144, 101–109. 
James-Todd, T., Stahlhut, R., Meeker, J.D., et al., 2012. Urinary phthalate metabolite 
concentrations and diabetes among women in the National Health and Nutrition 
Examination Survey (NHANES) 2001–2008. Environ. Health Perspect. 120, 
1307–1313. 
Jepsen, K.F., Abildtrup, A., Larsen, S.T., 2004. Monophthalates promote IL-6 and IL-8 
production in the human epithelial cell line A549. Toxicol. In Vitro 18, 265–269. 
Ji, H., Song, N., Ren, J., et al., 2019. Metabonomics reveals bisphenol A affects fatty acid 
and glucose metabolism through activation of LXR in the liver of male mice. Sci. Total 
Environ. 703. 
Kooijman, M.N., Kruithof, C.J., van Duijn, C.M., et al., 2016. The Generation R Study: 
design and cohort update 2017. Eur. J. Epidemiol. 31, 1243–1264. 
Kruithof, C.J., Kooijman, M.N., van Duijn, C.M., et al., 2014. The Generation R Study: 
Biobank update 2015. Eur. J. Epidemiol. 29, 911–927. 
Lang, I.A., Galloway, T.S., Scarlett, A., et al., 2008. Association of urinary bisphenol A 
concentration with medical disorders and laboratory abnormalities in adults. JAMA 
300, 1303–1310. 
Langsted, A., Nordestgaard, B.G., 2019. Nonfasting versus fasting lipid profile for cardi-
ovascular risk prediction. Pathology 51, 131–141. 
Laplante, M., Festuccia, W.T., Soucy, G., et al., 2007. Involvement of adipose tissues in the 
early hypolipidemic action of PPARgamma agonism in the rat. Am. J. Physiol. Regul. 
Integr. Comp. Physiol. 292, R1408–1417. 
Lee, K.I., Chiang, C.W., Lin, H.C., et al., 2016. Maternal exposure to di-(2-ethylhexyl) 
phthalate exposure deregulates blood pressure, adiposity, cholesterol metabolism and 
social interaction in mouse offspring. Arch. Toxicol. 90, 1211–1224. 
Li, G., Chang, H., Xia, W., et al., 2014. F0 maternal BPA exposure induced glucose in-
tolerance of F2 generation through DNA methylation change in Gck. Toxicol. Lett. 
228, 192–199. 
Li, M.X., Yeung, J.M., Cherny, S.S., et al., 2012. Evaluating the effective numbers of in-
dependent tests and significant p-value thresholds in commercial genotyping arrays 
and public imputation reference datasets. Hum. Genet. 131, 747–756. 
Mahalingaiah, S., Meeker, J.D., Pearson, K.R., et al., 2008. Temporal variability and 
predictors of urinary bisphenol A concentrations in men and women. Environ. Health 
Perspect. 116, 173–178. 
Martinez-Ibarra, A., Martinez-Razo, L.D., Vazquez-Martinez, E.R., et al., 2019. Unhealthy 
levels of phthalates and bisphenol A in Mexican pregnant women with gestational 
diabetes and its association to altered expression of miRNAs involved with metabolic 
disease. Int. J. Mol. Sci. 20. 
Mattison, D.R., Karyakina, N., Goodman, M., et al., 2014. Pharmaco- and toxicokinetics of 
selected exogenous and endogenous estrogens: a review of the data and identification 
of knowledge gaps. Crit. Rev. Toxicol. 44, 696–724. 
McCabe, C., Anderson, O.S., Montrose, L., et al., 2017. Sexually dimorphic effects of early- 
life exposures to endocrine disruptors: sex-specific epigenetic reprogramming as a 
potential mechanism. Curr. Environ. Health Rep. 4, 426–438. 
Meng, Z., Wang, D., Yan, S., et al., 2018. Effects of perinatal exposure to BPA and its 
alternatives (BPS, BPF and BPAF) on hepatic lipid and glucose homeostasis in female 
mice adolescent offspring. Chemosphere 212, 297–306. 
Miura, R., Araki, A., Minatoya, M., et al., 2019. An epigenome-wide analysis of cord blood 
DNA methylation reveals sex-specific effect of exposure to bisphenol A. Sci. Rep. 9, 
12369. 
Mose, T., Knudsen, L.E., Hedegaard, M., et al., 2007. Transplacental transfer of mono-
methyl phthalate and mono(2-ethylhexyl) phthalate in a human placenta perfusion 
system. Int. J. Toxicol. 26, 221–229. 
Nahar, M.S., Liao, C., Kannan, K., et al., 2015. In utero bisphenol A concentration, me-
tabolism, and global DNA methylation across matched placenta, kidney, and liver in 
the human fetus. Chemosphere 124, 54–60. 
Neier, K., Cheatham, D., Bedrosian, L.D., et al., 2019. Longitudinal metabolic impacts of 
perinatal exposure to phthalates and phthalate mixtures in mice. Endocrinology 160, 
1613–1630. 
Nguyen, A.N., de Barse, L.M., Tiemeier, H., et al., 2017. Maternal history of eating dis-
orders: Diet quality during pregnancy and infant feeding. Appetite 109, 108–114. 
Onyenekwu, C.P., Hoffmann, M., Smit, F., et al., 2014. Comparison of LDL-cholesterol 
estimate using the Friedewald formula and the newly proposed de Cordova formula 
with a directly measured LDL-cholesterol in a healthy South African population. Ann. 
Clin. Biochem. 51, 672–679. 
Pauwels, S., Ghosh, M., Duca, R.C., et al., 2017. Maternal intake of methyl-group donors 
affects DNA methylation of metabolic genes in infants. Clin. Epigenetics 9, 16. 
Perng, W., Watkins, D.J., Cantoral, A., et al., 2017. Exposure to phthalates is associated 
with lipid profile in peripubertal Mexican youth. Environ. Res. 154, 311–317. 
Philips, E.M., Jaddoe, V.W.V., Asimakopoulos, A.G., et al., 2018. Bisphenol and phthalate 
concentrations and its determinants among pregnant women in a population-based 
cohort in the Netherlands, 2004–5. Environ. Res. 161, 562–572. 
Rajagopal, G., Bhaskaran, R.S., Karundevi, B., 2019. Maternal di-(2-ethylhexyl) phthalate 
exposure alters hepatic insulin signal transduction and glucoregulatory events in rat 
F1 male offspring. J. Appl. Toxicol. 39, 751–763. 
Ranciere, F., Lyons, J.G., Loh, V.H., et al., 2015. Bisphenol A and the risk of cardiome-
tabolic disorders: a systematic review with meta-analysis of the epidemiological 
evidence. Environ. Health 14, 46. 
Russo, G., Barbato, F., Mita, D.G., et al., 2019. Occurrence of Bisphenol A and its ana-
logues in some foodstuff marketed in Europe. Food Chem. Toxicol. 131. 
Santos, S., Zugna, D., Pizzi, C., et al., 2019. Sources of confounding in life course epi-
demiology. J. Dev. Orig. Health Dis. 10, 299–305. 
Schettler, T., 2006;. Human exposure to phthalates via consumer products. Int. J. Androl. 
C.M. Sol, et al.   Environment International 144 (2020) 106063
11
29, 134–139 discussion 181–135. 
Somm, E., Schwitzgebel, V.M., Toulotte, A., et al., 2009. Perinatal exposure to bisphenol a 
alters early adipogenesis in the rat. Environ. Health Perspect. 117, 1549–1555. 
Stahlhut, R.W., Myers, J.P., Taylor, J.A., et al., 2018. Experimental BPA exposure and 
glucose-stimulated insulin response in adult men and women. J. Endocr. Soc. 2, 
1173–1187. 
Susiarjo, M., Xin, F., Bansal, A., et al., 2015. Bisphenol a exposure disrupts metabolic 
health across multiple generations in the mouse. Endocrinology 156, 2049–2058. 
Taylor, J.A., Sommerfeld-Sager, J.M., Meng, C.X., et al., 2018. Reduced body weight at 
weaning followed by increased post-weaning growth rate interacts with part-per- 
trillion fetal serum concentrations of bisphenol A (BPA) to impair glucose tolerance in 
male mice. PLoS ONE 13. 
Vafeiadi, M., Roumeliotaki, T., Myridakis, A., et al., 2016. Association of early life 
exposure to bisphenol A with obesity and cardiometabolic traits in childhood. 
Environ. Res. 146, 379–387. 
Vafeiadi, M., Myridakis, A., Roumeliotaki, T., et al., 2018. Association of early life ex-
posure to phthalates with obesity and cardiometabolic traits in childhood: sex specific 
associations. Front. Public Health 6, 327. 
Watkins, D.J., Peterson, K.E., Ferguson, K.K., et al., 2016. Relating phthalate and BPA 
exposure to metabolism in peripubescence: the role of exposure timing, sex, and 
puberty. J. Clin. Endocrinol. Metab. 101, 79–88. 
Ye, X., Pierik, F.H., Hauser, R., et al., 2008. Urinary metabolite concentrations of orga-
nophosphorous pesticides, bisphenol A, and phthalates among pregnant women in 
Rotterdam, the Netherlands: the Generation R study. Environ. Res. 108, 260–267. 
Zhao, F., Wang, H., Wei, P., et al., 2018. Impairment of bisphenol F on the glucose me-
tabolism of zebrafish larvae. Ecotoxicol. Environ. Saf. 165, 386–392.  
C.M. Sol, et al.   Environment International 144 (2020) 106063
12
